Interaction Guide · Research summary

Can I take Withania Somnifera with Meclizine?

Review Withania Somnifera with Meclizine: possible adverse effects, preparation details, evidence limits, and sources.

Prepared by Dr. Edward M.Kim, PharmD · Clinical Director, SupplementSafety editorial team

Research summary published · Prepared · Editorial update

The short answer

Some ashwagandha products cause drowsiness and may add to meclizine-related impairment. Review the actual root or leaf preparation; improved sleep in a trial does not establish the size of this interaction.

What this answer covers

Oral meclizine with the specific preparation described below.

Supplement or preparation
Withania somnifera
Medication ingredient
meclizine

Some products can make people drowsy

Federal guidance identifies drowsiness as a possible ashwagandha effect and notes potential interactions with sedatives. Meclizine’s own drowsiness warning makes that a reason for product-specific review.

The original sleep trial used a specific root extract

A placebo-controlled study found improved sleep and anxiety measures with one Withania somnifera root extract. It was not a meclizine interaction trial and cannot quantify added daytime impairment from the combination.

Root, leaf and mixed sleep products need separate assessment

The trial’s root preparation cannot automatically represent leaf extracts or mixtures with melatonin and other botanicals. Bring the complete label so the pharmacist can assess every ingredient rather than attributing all effects to the plant name.

Review the whole alertness burden

Bring the exact supplement label and all medicines to your pharmacist, particularly if meclizine already makes you sleepy, dizzy or confused. Avoid driving when affected. The reviewed evidence does not identify a supplement dose or hours-apart schedule that guarantees normal alertness.

Evidence and practical considerations

Side effects & toxicity

Some ashwagandha products cause drowsiness and may add to meclizine-related impairment. Review the actual root or leaf preparation; improved sleep in a trial does not establish the size of this interaction.

Exact scope
Oral meclizine with the specific preparation described below. with Oral meclizine; the hyoscine source, where relevant, is explicitly transdermal.
Medication form and route
oral

What remains uncertain

  • Conditional product-specific alertness concern. Root-extract sleep trial does not test meclizine co-use; no uniform all-preparation interaction rate or protective gap.

Factors that may matter: Exact preparation and amount; Other medicines with overlapping effects; Route and gut-transit status where relevant.

Research conclusion: supported with conditions · Evidence assessment: low

Read the supporting source summaries

Source 1: Current U.S. regulatory product labeling

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: Patients prescribed oral meclizine.

Meclizine may cause drowsiness; alcohol and other CNS depressants may increase impairment. The label discusses possible CYP2D6 inhibitor effects but does not establish a named botanical interaction.

How this applies: Exact active ingredient and oral-route context.

Label warnings do not measure every exact supplement pair or provide a universal safe supplement dose or interval.

Source 2: Federal supplement guidance

nccih.nih.gov · Source check Sep 10, 2026

Population: People considering the named botanical or supplement.

Some preparations cause drowsiness and may interact with sedative medicines.

How this applies: Product-specific precaution, not proof all preparations cause added meclizine impairment.

General guidance does not quantify this exact medication combination or establish a universal protective interval.

Source 3: Original human study

pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026

Population: Adults with insomnia in a randomized placebo-controlled trial.

Sleep and anxiety measures improved with the tested root extract.

How this applies: Sleep improvement is not proof of added medicine-related impairment.

Not a meclizine combination trial; abstract participant totals are inconsistent, so disputed subgroup counts are not adopted. Root and leaf preparations differ.

Research assessment: · Open full citations ↗

Review and change history

Publication status
Published research summary
Clinical review
Not yet recorded
DateUpdate
Article prepared
Initial source-checked research draft with exact preparation limits, contrary findings and source-access details. Clinical review not recorded.
Research summary published

Article revision: cac359fd4c4878d5

This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.

Full citations require verification. Reading this answer and the source summaries does not.

Taking other supplements or medications?

Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.

Open the interaction checker

Information, not medical advice. Do not change prescribed treatment based on this guide.